Anxiety in Multiple Sclerosis: Psychometric properties of the State-Trait Anxiety Inventory

G. Santangelo, R. Sacco, M. Siciliano, A. Bisecco, G. Muzzo, R. Docimo, M. De Stefano, S. Bonavita, L. Lavorgna, G. Tedeschi, L. Trojano, A. Gallo

Research output: Contribution to journalArticle

Abstract

Objective: The aims of the present study were to examine psychometric properties of the Spielberger State-Trait Anxiety Inventory (STAI-Y-1 and STAI-Y-2, respectively) in a Multiple Sclerosis (MS) population and to identify a cut-off score to detect those MS patients with high level of state and/or trait anxiety who could be more vulnerable to development of depression and/or cognitive defects. Material and methods: The STAI-Y-1 and STAI-Y-2 was completed by a group of patients (n = 175) affected by MS and a group of healthy subjects (n = 150) matched for age, educational level, and gender. In MS patients internal consistency, divergent and discriminant validities were evaluated. Construct validity was examined by exploratory factor analysis for each scale. Results: There was no missing data, no floor or ceiling effects for both scales. The two scales showed high internal consistency, good divergent, and Known-groups validities. To identify high levels of state and trait anxiety in a patient with MS, we proposed three gender specific screening cut-off values (1, 1.5, 2 SD) for the STAI-Y-1 and the STAI-Y-2. Conclusions: The findings showed that the STAI-Y-1 and the STAI-Y-2 are a valid tool for clinical use in MS patients and can be useful to measure the severity of anxiety and to identify those patients with high anxiety to introduce them in specific non-pharmacological intervention.

Original languageEnglish
Article number134 (6)
Pages (from-to)458-466
JournalActa Neurologica Scandinavica
DOIs
Publication statusPublished - Dec 2016

Fingerprint

Psychometrics
Multiple Sclerosis
Anxiety
Equipment and Supplies
Statistical Factor Analysis
Healthy Volunteers
Depression
Population

Keywords

  • Anxiety
  • Cognitive deficits
  • Depression
  • Multiple sclerosis
  • STAI-Y
  • Validation

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Santangelo, G., Sacco, R., Siciliano, M., Bisecco, A., Muzzo, G., Docimo, R., ... Gallo, A. (2016). Anxiety in Multiple Sclerosis: Psychometric properties of the State-Trait Anxiety Inventory. Acta Neurologica Scandinavica, 458-466. [134 (6)]. https://doi.org/10.1111/ane.12564

Anxiety in Multiple Sclerosis : Psychometric properties of the State-Trait Anxiety Inventory. / Santangelo, G.; Sacco, R.; Siciliano, M.; Bisecco, A.; Muzzo, G.; Docimo, R.; De Stefano, M.; Bonavita, S.; Lavorgna, L.; Tedeschi, G.; Trojano, L.; Gallo, A.

In: Acta Neurologica Scandinavica, 12.2016, p. 458-466.

Research output: Contribution to journalArticle

Santangelo, G, Sacco, R, Siciliano, M, Bisecco, A, Muzzo, G, Docimo, R, De Stefano, M, Bonavita, S, Lavorgna, L, Tedeschi, G, Trojano, L & Gallo, A 2016, 'Anxiety in Multiple Sclerosis: Psychometric properties of the State-Trait Anxiety Inventory', Acta Neurologica Scandinavica, pp. 458-466. https://doi.org/10.1111/ane.12564
Santangelo G, Sacco R, Siciliano M, Bisecco A, Muzzo G, Docimo R et al. Anxiety in Multiple Sclerosis: Psychometric properties of the State-Trait Anxiety Inventory. Acta Neurologica Scandinavica. 2016 Dec;458-466. 134 (6). https://doi.org/10.1111/ane.12564
Santangelo, G. ; Sacco, R. ; Siciliano, M. ; Bisecco, A. ; Muzzo, G. ; Docimo, R. ; De Stefano, M. ; Bonavita, S. ; Lavorgna, L. ; Tedeschi, G. ; Trojano, L. ; Gallo, A. / Anxiety in Multiple Sclerosis : Psychometric properties of the State-Trait Anxiety Inventory. In: Acta Neurologica Scandinavica. 2016 ; pp. 458-466.
@article{b54d00e3ced04b5ab51b1505260fd60c,
title = "Anxiety in Multiple Sclerosis: Psychometric properties of the State-Trait Anxiety Inventory",
abstract = "Objective: The aims of the present study were to examine psychometric properties of the Spielberger State-Trait Anxiety Inventory (STAI-Y-1 and STAI-Y-2, respectively) in a Multiple Sclerosis (MS) population and to identify a cut-off score to detect those MS patients with high level of state and/or trait anxiety who could be more vulnerable to development of depression and/or cognitive defects. Material and methods: The STAI-Y-1 and STAI-Y-2 was completed by a group of patients (n = 175) affected by MS and a group of healthy subjects (n = 150) matched for age, educational level, and gender. In MS patients internal consistency, divergent and discriminant validities were evaluated. Construct validity was examined by exploratory factor analysis for each scale. Results: There was no missing data, no floor or ceiling effects for both scales. The two scales showed high internal consistency, good divergent, and Known-groups validities. To identify high levels of state and trait anxiety in a patient with MS, we proposed three gender specific screening cut-off values (1, 1.5, 2 SD) for the STAI-Y-1 and the STAI-Y-2. Conclusions: The findings showed that the STAI-Y-1 and the STAI-Y-2 are a valid tool for clinical use in MS patients and can be useful to measure the severity of anxiety and to identify those patients with high anxiety to introduce them in specific non-pharmacological intervention.",
keywords = "Anxiety, Cognitive deficits, Depression, Multiple sclerosis, STAI-Y, Validation",
author = "G. Santangelo and R. Sacco and M. Siciliano and A. Bisecco and G. Muzzo and R. Docimo and {De Stefano}, M. and S. Bonavita and L. Lavorgna and G. Tedeschi and L. Trojano and A. Gallo",
year = "2016",
month = "12",
doi = "10.1111/ane.12564",
language = "English",
pages = "458--466",
journal = "Acta Neurologica Scandinavica",
issn = "0001-6314",
publisher = "Wiley Blackwell",

}

TY - JOUR

T1 - Anxiety in Multiple Sclerosis

T2 - Psychometric properties of the State-Trait Anxiety Inventory

AU - Santangelo, G.

AU - Sacco, R.

AU - Siciliano, M.

AU - Bisecco, A.

AU - Muzzo, G.

AU - Docimo, R.

AU - De Stefano, M.

AU - Bonavita, S.

AU - Lavorgna, L.

AU - Tedeschi, G.

AU - Trojano, L.

AU - Gallo, A.

PY - 2016/12

Y1 - 2016/12

N2 - Objective: The aims of the present study were to examine psychometric properties of the Spielberger State-Trait Anxiety Inventory (STAI-Y-1 and STAI-Y-2, respectively) in a Multiple Sclerosis (MS) population and to identify a cut-off score to detect those MS patients with high level of state and/or trait anxiety who could be more vulnerable to development of depression and/or cognitive defects. Material and methods: The STAI-Y-1 and STAI-Y-2 was completed by a group of patients (n = 175) affected by MS and a group of healthy subjects (n = 150) matched for age, educational level, and gender. In MS patients internal consistency, divergent and discriminant validities were evaluated. Construct validity was examined by exploratory factor analysis for each scale. Results: There was no missing data, no floor or ceiling effects for both scales. The two scales showed high internal consistency, good divergent, and Known-groups validities. To identify high levels of state and trait anxiety in a patient with MS, we proposed three gender specific screening cut-off values (1, 1.5, 2 SD) for the STAI-Y-1 and the STAI-Y-2. Conclusions: The findings showed that the STAI-Y-1 and the STAI-Y-2 are a valid tool for clinical use in MS patients and can be useful to measure the severity of anxiety and to identify those patients with high anxiety to introduce them in specific non-pharmacological intervention.

AB - Objective: The aims of the present study were to examine psychometric properties of the Spielberger State-Trait Anxiety Inventory (STAI-Y-1 and STAI-Y-2, respectively) in a Multiple Sclerosis (MS) population and to identify a cut-off score to detect those MS patients with high level of state and/or trait anxiety who could be more vulnerable to development of depression and/or cognitive defects. Material and methods: The STAI-Y-1 and STAI-Y-2 was completed by a group of patients (n = 175) affected by MS and a group of healthy subjects (n = 150) matched for age, educational level, and gender. In MS patients internal consistency, divergent and discriminant validities were evaluated. Construct validity was examined by exploratory factor analysis for each scale. Results: There was no missing data, no floor or ceiling effects for both scales. The two scales showed high internal consistency, good divergent, and Known-groups validities. To identify high levels of state and trait anxiety in a patient with MS, we proposed three gender specific screening cut-off values (1, 1.5, 2 SD) for the STAI-Y-1 and the STAI-Y-2. Conclusions: The findings showed that the STAI-Y-1 and the STAI-Y-2 are a valid tool for clinical use in MS patients and can be useful to measure the severity of anxiety and to identify those patients with high anxiety to introduce them in specific non-pharmacological intervention.

KW - Anxiety

KW - Cognitive deficits

KW - Depression

KW - Multiple sclerosis

KW - STAI-Y

KW - Validation

UR - http://www.scopus.com/inward/record.url?scp=84958212154&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958212154&partnerID=8YFLogxK

U2 - 10.1111/ane.12564

DO - 10.1111/ane.12564

M3 - Article

AN - SCOPUS:84958212154

SP - 458

EP - 466

JO - Acta Neurologica Scandinavica

JF - Acta Neurologica Scandinavica

SN - 0001-6314

M1 - 134 (6)

ER -